Discovery of Novel Reductive Elimination Pathway for 10-Hydroxywarfarin
Coumadin (R/S-warfarin) anticoagulant therapy is highly efficacious in preventing the formation of blood clots; however, significant inter-individual variations in response risks over or under dosing resulting in adverse bleeding events or ineffective therapy, respectively. Levels of pharmacological...
Main Authors: | Dakota L. Pouncey, Dustyn A. Barnette, Riley W. Sinnott, Sarah J. Phillips, Noah R. Flynn, Howard P. Hendrickson, S. Joshua Swamidass, Grover P. Miller |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.805133/full |
Similar Items
-
Simultaneous determination of warfarin and 7-hydroxywarfarin in rat plasma by HPLC-FLD
by: Zayed Aref, et al.
Published: (2020-09-01) -
Simultaneous Characterization and Determination of Warfarin and Its Hydroxylation Metabolites in Rat Plasma by Chiral Liquid Chromatography-Tandem Mass Spectrometry
by: Shasha Jin, et al.
Published: (2022-05-01) -
Piperine Alters the Pharmacokinetics and Anticoagulation of Warfarin in Rats
by: Zayed A, et al.
Published: (2020-06-01) -
Development of a rapid HPLC-fluorescence method for monitoring warfarin metabolites formation: In vitro studies for evaluating the effect of piperine on warfarin metabolism and plasma coagulation
by: Aref L. Zayed, et al.
Published: (2024-05-01) -
Potential factors affecting the anticoagulation control in patients treated with warfarin: Results WARFARIN-TR study
by: Salih Kilic, et al.
Published: (2018-01-01)